TL;DR
This study reveals that the brain's defense mechanisms, specifically host restriction factors (RFs), are altered in individuals with HIV, particularly in cases of encephalitis, and these changes correlate with viral load. Furthermore, antiretroviral therapy (ART) can suppress these defense factors in the brain, while interrupting ART can lead to their resurgence, suggesting a complex interplay between HIV, the brain's immune response, and treatment.
What Problem Does This Paper Address?
Despite effective antiretroviral therapy (ART), HIV can persist in the brain, leading to neurocognitive impairments and even encephalitis. The exact mechanisms behind this persistence and the brain's response to HIV are not fully understood. Specifically, how the brain's intrinsic antiviral defense systems, known as host restriction factors (RFs), are regulated in the context of HIV infection and its neurological consequences (like HAND and HIVE) remained largely unknown. This paper aims to fill this knowledge gap by investigating the expression patterns of RFs in the brain across different HIV clinical statuses and exploring the impact of ART on these factors.
Methods
The researchers employed a multi-pronged approach:
- RNA-sequencing (RNA-seq): This high-throughput technique was used to analyze the transcriptomic profile of RF genes in post-mortem brain tissue from four groups of individuals: uninfected controls, HIV-infected individuals without neurological disease, HIV-infected individuals with HAND, and HIV-infected individuals with HAND and encephalitis (HIVE).
- Quantitative Reverse Transcription PCR (qRT-PCR): This method was used to validate the RNA-seq findings for specific RF genes, providing more precise measurements of their expression levels.
- Droplet Digital PCR (ddPCR): This technique was utilized to quantify the viral burden (RNA, DNA, and integrated DNA) in brain tissues.
- Machine Learning (Shrinkage Discriminant Analysis): This approach was applied to identify key variables (clinical factors and RF gene expression) that could distinguish between different clinical groups, particularly those with HAND.
- Non-Human Primate Model: To investigate the impact of ART, SIV-infected rhesus macaques were used. These animals were categorized into groups with no ART, ART interruption, and suppressive ART, allowing for the analysis of RF expression under different treatment conditions.
Datasets
The study utilized two primary datasets:
- Human Brain Tissue Cohort: Post-mortem cerebral cortex samples were obtained from four groups of individuals:
-
HIV-uninfected (HIV[-], n=10)
- HIV-infected without pre-mortem brain disease (HIV[+], n=10)
- HIV-infected with neurocognitive disorders (HIV[+]/HAND, n=10)
- HIV-infected with neurocognitive disorders and encephalitis (HIV[+]/HIVE, n=10) These samples were sourced from the National NeuroAIDS Tissue Consortium (NNTC).
-
SIV-infected Non-Human Primate Cohort: Chinese rhesus macaques were infected with SIVmac251 and then assigned to three groups based on their ART treatment status:
- SIV-infected and ART naïve (SIV[+], n=7)
- SIV-infected with treatment interruption (SIV[+]/ATI, n=8)
- SIV-infected with suppressive ART (SIV[+]/ART, n=3)
Key Insights and Ideas
- Brain's Antiviral Defenses are Dysregulated in HIV: The study highlights that the brain's innate immune system, through RFs, is actively responding to HIV, but this response is not always protective and can be altered by the disease state.
- HIVE is Associated with Heightened RF Expression: Individuals with HIV encephalitis (HIVE) showed significantly increased expression of many RFs in their brain tissue, suggesting an intense, albeit potentially detrimental, immune response.
- MAN1B1 as a Potential Biomarker: The machine learning analysis pinpointed MAN1B1 as a key gene that could distinguish HIV-infected individuals with HAND from those without cognitive impairment, suggesting its potential as a diagnostic or prognostic marker.
- ART Dampens Brain RFs: In the SIV macaque model, effective ART was associated with reduced expression of several RFs in the brain, indicating that ART might suppress the brain's intrinsic antiviral defenses.
- ART Interruption Re-activates RFs: Conversely, interrupting ART in the macaque model led to an increase in the expression of certain RFs, suggesting that viral resurgence might trigger these defense mechanisms.
Key Results
- Increased RFs in HIVE: A significant upregulation of RFs was observed in the brains of HIV[+]/HIVE individuals compared to controls and other HIV groups. This upregulation correlated with higher brain viral loads.
- MAN1B1 Distinguishes HAND: Machine learning identified MAN1B1 as a critical variable for distinguishing HIV[+] from HIV[+]/HAND groups, with an importance value of 100.
- ART Impact in Macaques: SIV-infected macaques on ART showed diminished RF expression compared to untreated or ART-interrupted groups. Specifically, OAS3, RNASEL, MX2, and MAN1B1 were induced upon ART interruption.
- OAS Family Significance: The OAS gene family and RNASEL were consistently upregulated in HIV[+] patients with HAND and HIVE, and the OAS family was identified as a key distinguishing factor between HAND and HIVE groups.
Limitations and Future Work
The authors acknowledge several limitations:
- Sample Size: The human cohort had a relatively small sample size, which could limit the generalizability of the findings.
- ART Status Uncertainty: The precise ART history and adherence levels for the human cohort were not always clear, making it difficult to definitively link ART exposure to specific RF profiles.
- RNA vs. Protein Levels: The study focused on mRNA expression, and the correlation with actual protein levels and their functional impact remains to be investigated.
- Discordance in Downregulated Genes: Some discrepancies were observed between RNA-seq and qRT-PCR for downregulated RFs, potentially due to limitations in RNA-seq data or the presence of pseudo-genes.
Future work suggested by the authors includes:
- Investigating the protein expression levels of MAN1B1 and its associated protein ERMAN1 in the brains and CSF of PWH.
- Exploring the potential of MAN1B1 as a biomarker for neurocognitive impairments.
- Further research into the cellular localization and host protein-protein interactions of RFs.
- Conducting studies with larger sample sizes and more detailed ART information.
- Examining the functional consequences of RF dysregulation in HAND and HIVE.
Summary updated